Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-11-30

Clinical Trial Update: Ezopiclone Improves the Quality of Overnight Polysomnography [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting that Ezopiclone improves the quality of overnight polysomnography in patients with Obstructive Sleep Apnea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ezopiclone (Ezopiclone)

Snippet

Sponsor: Walter Reed Army Medical Center | Conditions: Obstructive Sleep Apnea | Phase 4 | Status: COMPLETED